Ubs Asset Management Americas Inc Vir Biotechnology, Inc. Transaction History

Ubs Asset Management Americas Inc

$446 Billion
Q3 2025

A detailed history of Ubs Asset Management Americas Inc transactions in Vir Biotechnology, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 143,938 shares of VIR stock, worth $810,370. This represents 0.0% of its overall portfolio holdings.

Number of Shares

143,938

Previous 294,383 51.11%

Holding current value

$810,370

Previous $1.48 Million 44.64%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	SELL	$4.28 - $5.93 $643,904 - $892,138	-150,445 Reduced 51.11%	143,938 $821,000
Q2 2025 Aug 14, 2025	BUY	$4.5 - $6.48 $428,940 - $617,673	95,320 Added 47.88%	294,383 $1.48 Million
Q1 2025 May 19, 2025	BUY	$6.48 - $12.48 $114,942 - $221,370	17,738 Added 9.78%	199,063 $1.29 Million
Q4 2024 Feb 14, 2025	BUY	$6.74 - $10.17 $276,029 - $416,502	40,954 Added 29.18%	181,325 $1.33 Million
Q3 2024 Nov 14, 2024	SELL	$7.26 - $10.7 $219,164 - $323,011	-30,188 Reduced 17.7%	140,371 $1.05 Million

Q2 2024 Aug 13, 2024	BUY	$7.63 - $12.66 $598,955 - $993,810	78,500 Added 85.27%	170,559 $1.52 Million
Q4 2023 Feb 14, 2024	BUY	$7.76 - $10.29 $90,365 - $119,827	11,645 Added 14.48%	92,059 $926,000
Q3 2023 Nov 13, 2023	SELL	$9.14 - $24.62 $80,697 - $217,369	-8,829 Reduced 9.89%	80,414 $753,000
Q1 2023 May 15, 2023	BUY	$22.26 - $30.85 $389,505 - $539,813	17,498 Added 24.39%	89,243 $2.08 Million
Q4 2022 Feb 14, 2023	BUY	$19.96 - $28.22 $169,939 - $240,265	8,514 Added 13.46%	71,745 $1.82 Million
Q3 2022 Nov 14, 2022	SELL	$18.26 - $31.1 $280,017 - $476,918	-15,335 Reduced 19.52%	63,231 $1.22 Million
Q2 2022 Aug 12, 2022	BUY	$19.08 - $26.7 $211,520 - $295,996	11,086 Added 16.43%	78,566 $2 Million
Q1 2022 May 16, 2022	BUY	$21.19 - $40.01 $51,661 - $97,544	2,438 Added 3.75%	67,480 $1.74 Million
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $40,973 - $71,481	1,323 Added 2.08%	65,042 $2.72 Million
Q3 2021 Nov 15, 2021	BUY	$34.9 - $54.54 $19,160 - $29,942	549 Added 0.87%	63,719 $2.77 Million
Q2 2021 Aug 16, 2021	BUY	$38.75 - $51.0 $2.06 Million - $2.71 Million	53,111 Added 527.99%	63,170 $2.99 Million
Q4 2020 Mar 01, 2021	SELL	$25.51 - $43.38 $3.02 Million - $5.13 Million	-118,199 Reduced 92.16%	10,059 $269,000
Q3 2020 Nov 13, 2020	SELL	$28.28 - $53.6 $610,819 - $1.16 Million	-21,599 Reduced 14.41%	128,258 $4.4 Million
Q2 2020 Aug 14, 2020	BUY	$27.89 - $47.86 $4.18 Million - $7.17 Million	149,857 New	149,857 $6.14 Million

Others Institutions Holding VIR

# of Institutions

243

Shares Held

106M

Call Options Held

246K

Put Options Held

126K

View Full List

About Vir Biotechnology, Inc.

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $747M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

More about VIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Account

Ubs Asset Management Americas Inc Vir Biotechnology, Inc. Transaction History